搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella sp. Sulfate adenylyltransferase subunit 2 (cysD) CSB-YP610976SAAN
CSB-EP610976SAAN
CSB-BP610976SAAN
CSB-MP610976SAAN
CSB-EP610976SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Isoleucine--tRNA ligase (ileS), partial CSB-YP610977SAAN
CSB-EP610977SAAN
CSB-BP610977SAAN
CSB-MP610977SAAN
CSB-EP610977SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Iron-sulfur cluster insertion protein ErpA (erpA) CSB-YP610978SAAN
CSB-EP610978SAAN
CSB-BP610978SAAN
CSB-MP610978SAAN
CSB-EP610978SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Na (+)/H (+) antiporter nhaA (nhaA), partial CSB-YP610979SAAN
CSB-EP610979SAAN
CSB-BP610979SAAN
CSB-MP610979SAAN
CSB-EP610979SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. UPF0597 protein Shewmr4_2793 (Shewmr4_2793) CSB-YP610980SAAN
CSB-EP610980SAAN
CSB-BP610980SAAN
CSB-MP610980SAAN
CSB-EP610980SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 1-deoxy-D-xylulose-5-phosphate synthase (dxs), partial CSB-YP610981SAAN
CSB-EP610981SAAN
CSB-BP610981SAAN
CSB-MP610981SAAN
CSB-EP610981SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 30S ribosomal protein S2 (rpsB) CSB-YP610982SAAN
CSB-EP610982SAAN
CSB-BP610982SAAN
CSB-MP610982SAAN
CSB-EP610982SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase (fabZ) CSB-YP610983SAAN
CSB-EP610983SAAN
CSB-BP610983SAAN
CSB-MP610983SAAN
CSB-EP610983SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Glycosyl hydrolase family 109 protein 2 (Shewmr4_2535) CSB-YP610984SAAN
CSB-EP610984SAAN
CSB-BP610984SAAN
CSB-MP610984SAAN
CSB-EP610984SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP610985SAAN
CSB-EP610985SAAN
CSB-BP610985SAAN
CSB-MP610985SAAN
CSB-EP610985SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Uracil phosphoribosyltransferase (upp) CSB-YP610986SAAN
CSB-EP610986SAAN
CSB-BP610986SAAN
CSB-MP610986SAAN
CSB-EP610986SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Chaperone protein htpG (htpG), partial CSB-YP610987SAAN
CSB-EP610987SAAN
CSB-BP610987SAAN
CSB-MP610987SAAN
CSB-EP610987SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Asparagine--tRNA ligase (asnS) CSB-YP610988SAAN
CSB-EP610988SAAN
CSB-BP610988SAAN
CSB-MP610988SAAN
CSB-EP610988SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Deoxyguanosinetriphosphate triphosphohydrolase-like protein (Shewmr4_2042) CSB-YP610989SAAN
CSB-EP610989SAAN
CSB-BP610989SAAN
CSB-MP610989SAAN
CSB-EP610989SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Outer-membrane lipoprotein carrier protein (lolA) CSB-YP610990SAAN
CSB-EP610990SAAN
CSB-BP610990SAAN
CSB-MP610990SAAN
CSB-EP610990SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Phosphoserine aminotransferase (serC) CSB-YP610991SAAN
CSB-EP610991SAAN
CSB-BP610991SAAN
CSB-MP610991SAAN
CSB-EP610991SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Thiazole synthase (thiG) CSB-YP610992SAAN
CSB-EP610992SAAN
CSB-BP610992SAAN
CSB-MP610992SAAN
CSB-EP610992SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP610993SAAN
CSB-EP610993SAAN
CSB-BP610993SAAN
CSB-MP610993SAAN
CSB-EP610993SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Beta-hexosaminidase (nagZ) CSB-YP610994SAAN
CSB-EP610994SAAN
CSB-BP610994SAAN
CSB-MP610994SAAN
CSB-EP610994SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Putative arginyl-tRNA--protein transferase (ate) CSB-YP610995SAAN
CSB-EP610995SAAN
CSB-BP610995SAAN
CSB-MP610995SAAN
CSB-EP610995SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>